Blog

January 13, 2020 – HAUPPAUGE, N.Y.—SightMD (or the “Company”), a multi-specialty ophthalmology platform, today announced a strategic partnership with Spencer E. Sherman, M.D., P.C., a Manhattan-based ophthalmology practice. Sight Growth Partners, the administrative services provider for SightMD, will also serve Dr. Sherman in all administrative manners. The acquisition represents SightMD’s third office in Manhattan, with… Read More

Hauppauge, NY – January 6, 2020 – SightMD (or the “Company”), a Sight Growth Partners managed practice and leading multi-specialty ophthalmology platform, today announced that it has hired retinal specialist Gaurav Chandra, M.D. to join its growing team of over 80 providers in the Tri-state area. Dr. Chandra is a fellowship-trained ophthalmologist specializing in medical… Read More

In an article written in Ocular Surgery News, Dr. Alanna Nattis summarized that before recommending a corneal transplant for keratoconus patients, corneal cross-linking should often be discussed and considered as a viable treatment for keratoconus patients of all ages with keratoconus due to its ability to halt or slow the progression of the disease. Keratoconus… Read More

In a co-authored press release, Dr. Alanna Nattis discussed the importance of achieving optimal refractive outcomes during cataract surgery carefully managing and executing limbal relaxing incisions and astigmatic keratotomies. She added that astigmatic keratotomies and limbal relaxing incisions alone or during cataract surgery provide today’s surgeons with a keystone procedure that improves patient quality of… Read More

In an article to help determine how bacteria within the Meibomian Glands influenced ocular surface disease, Dr. Nattis and her co-authors concluded that basic symptoms of the ocular surface disease do not necessarily correlate with clinical exam findings nor positive culture findings. They argued that the bacterial burden should be reconsidered as a direct risk… Read More

In an article published in Expert Opinion on Pharmacotherapy, Dr. Alanna Nattis outlined how the first medication approved in the United States for the treatment of signs and symptoms of Dry Eye Disease (Lifitegrast) fits into today’s treatment regime for Dry Eye Disease. Dr. Nattis pointed out that DED is a common ocular surface disorder that can… Read More

In an article published by ASCRS & ESCRS, Dr. Alanna Nattis discussed the outcomes achieved in a study with Keratoconus patients who were first treated with corneal cross-linking and followed up with a topography-guided PRK procedure.  Dr. Nattis reported that the participants reviewed patients who were diagnosed with keratoconus who had been treated with corneal cross-linking (CXL). After their CXL procedure,… Read More

In a case presented in Cataract & Refractive Surgery Today of a 73-year-old woman who experienced decreased vision in her post-cataract eye after she fell and dislodged her intraocular lens implant (IOL), Dr. Alanna Nattis and her co-authors reviewed treatment strategies in this challenging situation.  Dr. Nattis indicated she would either attempt to reposition the… Read More

In a co-authored article by the American Academy of Ophthalmology, Dr. Alanna Nattis discusses a case presentation of a 77-year-old woman who fell on her face two weeks after cataract surgery, causing internal bleeding within the eye and increased intraocular pressure. In addition, there was an apparent loss of the entire iris tissue. The condition… Read More

In the article in The Ophthalmic ASC, Dr. Nattis discusses how valuable cross-linking was for patients with keratoconus, and how this was exemplified during her cornea fellowship training.  She reported that cross-linking enabled surgeons to not only prevent the progression of the condition but also provide options for visual improvement after cross-linking. To read the… Read More